Biologics in severe asthma: Which one, When and Where?

Hitasha Rupani; Anna Murphy; Katie Bluer; Charlotte Renwick; Peter McQuitty; David J. Jackson; Liam G. Heaney; Rekha Chaudhuri; Andrew Menzies-Gow; James Calvert; Salman Siddiqui

doi:10.1111/cea.13989

Biologics in severe asthma: Which one, When and Where?

Hitasha Rupani^*, Anna Murphy, Katie Bluer, Charlotte Renwick, Peter McQuitty, David J. Jackson, Liam G. Heaney, Rekha Chaudhuri, Andrew Menzies-Gow, James Calvert, Salman Siddiqui

^*Corresponding author for this work

Peter Gorer Department of Immunobiology

Research output: Contribution to journal › Letter › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	1225-1228
Number of pages	4
Journal	Clinical and Experimental Allergy
Volume	51
Issue number	9
DOIs	https://doi.org/10.1111/cea.13989
Publication status	Published - Sept 2021

Access to Document

10.1111/cea.13989

Cite this

@article{e8089799c38640c4ab21acb26d3cb8e9,

title = "Biologics in severe asthma: Which one, When and Where?",

author = "Hitasha Rupani and Anna Murphy and Katie Bluer and Charlotte Renwick and Peter McQuitty and Jackson, {David J.} and Heaney, {Liam G.} and Rekha Chaudhuri and Andrew Menzies-Gow and James Calvert and Salman Siddiqui",

note = "Funding Information: We would like to acknowledge the following contributions to this work: members of NHS Improving Values Severe Asthma collaborative (Claire Duffus, Graham Miller, Hannah Joplin, Helen Potter, Susanna Taylor and Teresa Warr), members of the UK Severe Asthma Registry and members of the British Thoracic Society Specialist Advisory Group for Asthma. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = sep,

doi = "10.1111/cea.13989",

language = "English",

volume = "51",

pages = "1225--1228",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "Blackwell Publishing",

number = "9",

}

TY - JOUR

T1 - Biologics in severe asthma

T2 - Which one, When and Where?

AU - Rupani, Hitasha

AU - Murphy, Anna

AU - Bluer, Katie

AU - Renwick, Charlotte

AU - McQuitty, Peter

AU - Jackson, David J.

AU - Heaney, Liam G.

AU - Chaudhuri, Rekha

AU - Menzies-Gow, Andrew

AU - Calvert, James

AU - Siddiqui, Salman

N1 - Funding Information: We would like to acknowledge the following contributions to this work: members of NHS Improving Values Severe Asthma collaborative (Claire Duffus, Graham Miller, Hannah Joplin, Helen Potter, Susanna Taylor and Teresa Warr), members of the UK Severe Asthma Registry and members of the British Thoracic Society Specialist Advisory Group for Asthma. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85111100516&partnerID=8YFLogxK

U2 - 10.1111/cea.13989

DO - 10.1111/cea.13989

M3 - Letter

AN - SCOPUS:85111100516

SN - 0954-7894

VL - 51

SP - 1225

EP - 1228

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 9

ER -

Biologics in severe asthma: Which one, When and Where?

Access to Document

Other files and links

Cite this